Status and phase
Conditions
Treatments
About
The purpose of the trial is to verify the effectiveness and safety of glimepiride compared with sitagliptin as an add-on therapy to metformin in severe insulin deficiency diabetes.
Full description
This clinical trial is a multi-centre, prospective, intervention, randomized-controlled clinical trial, and uses a superiority test to determine whether the experimental group is superior to the control group in terms of main efficacy endpoints.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
192 participants in 2 patient groups
Loading...
Central trial contact
Xiantong Zou, MD.Ph.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal